Pharmaceutical Packaging Market Size, Share & Trends Estimation Report By Material (Plastic, Glass, Metals, ),By Product Type (Bottles, Caps & Closures, Pre-Fillable Inhalers, ),By Drug Delivery Mode (Oral Drug Delivery Packaging, Injectable Packaging, ),By Packaging Type (Primary, Tertiary), By Region, And Segment Forecasts, 2023 - 2030
The Global Pharmaceutical Packaging Market Size Was Valued At USD 95.36 Billion In 2021. The Market Is Projected To Grow From USD 101.59 Billion In 2022 To USD 150.78 Billion By 2029, Exhibiting A CAGR Of 5.8% During The Forecast Period.
Pharmaceutical Packaging Market Overview:
The global COVID-19 pandemic has been unprecedented and shocking. Across all regions, the demand for pharmaceutical packaging is higher than expected compared to levels before the pandemic. Based on our research, the global market for pharmaceutical packaging grew by 6.7% between 2019 and 2020.
Because of growth that has never been seen before, the pharmaceutical industry is growing quickly. How medicine is packaged mostly depends on how common communicable and non-communicable diseases are. When transporting and storing drugs, these ways to package them keep them safe, secure, and stored. There are a lot of rules about how to use these solutions to keep the medicines safe from physical damage and other factors that could cause contamination before they are used. During the product's shelf life, the packaging can be used to promote the product and set it apart from the competition. Because the demand for pharmaceutical drugs and medicines is going up, there will be a rise in the amount of packaging used for them.
Because new ways to package drugs have been made, there is a need for pharmaceutical packaging. The new system for packaging drugs puts together single-dose vaccine units like prefilled inhalers and syringes. Traditional syringes and vials can be replaced with these items. The prefilled inhalers and syringes are made so that the drugs inside don't come into direct contact with the patient or the outside world. This keeps the drugs from getting contaminated. It also cuts down on waste and increases patient compliance by giving them a metered dose they can give themselves. Demand for these products is growing because more people are getting older and there are more diseases like diabetes and asthma. This will help new drug plastics group packaging systems get made.
The pharmaceutical industry is growing quickly, especially in developing countries like China, India, and Brazil, as well as in developed countries like the United States, the United Kingdom, and Germany. The growth is due to a growing population, more technological advances, a greater awareness of health care, the use of advanced manufacturing processes, more money being spent on public health care, and new rules put in place by the government to stop the spread of infectious diseases. Also, the growth of the pharmaceutical industry is likely to be helped by the rising demand for biological products and new treatments like cell and gene therapies.
For example, the European Federation of Pharmaceutical Industries and Association says that in 2021, 49.1% of all pharmaceutical sales were made in North America, while only 23.4% were made in Europe. According to IQVIA, 64.4% of sales of new medicines that came out between 2016 and 2021 were in the US, while 16.8% were in Europe (top 5 markets).
Developing countries should use more generic drugs to help the market grow.
Generic drugs are cheap, so they are being used more and more in developing countries. This will increase the need for packaging for pharmaceuticals. A generic drug is a pharmaceutical drug that has the same chemical ingredients, dosage, intended use, side effects, and way to take it as the original drug. Many companies are putting money into making generic drugs so they can sell cheaper medicines. This packaging is an important part of making generic drugs because it is used to pack and protect drugs while they are being stored or shipped. So, the use of pharmaceutical packaging will be driven by the rising demand for generic drugs.
Counterfeit pharmaceutical drugs are fake medicines that have the wrong ingredients or none at all. They can also be contaminated. These fake pharmaceutical drugs are against the law and bad for your health. Because of third-shift packaging, which is when contract manufacturers try to make more money by making more secret drugs and selling them to counterfeiters, the number of fake drugs is going up. So, fake pharmaceutical drugs are expected to cut into the market share of pharmaceutical packaging.
Most of the packaging for medicines is made from plastic, which is the most important raw material. The majority of this packaging is made of plastics like polyvinyl chloride (PVC), polypropylene (PP), polycarbonate (PC), high-impact polystyrene (HIPS), polyethylene terephthalate (PET), and high-density polyethylene (HDPE). Plastics are easy to shape into any size or shape, have protective qualities, and are cheap, so they are a good choice for packaging pharmaceutical preparations. These plastics keep drugs from getting broken or contaminated by dirt. It is used on bottles, caps, blister packs, jars and canisters, and overwrap.
Paper and paperboard are the second most common materials used in the pharmaceutical industry. This is because they are light and cheap. Most of the time, it is used for second and third packaging. Carton, shrink wrap, boxes, and cardboard are all made from paper and paperboard. Glass packaging is clear, strong, long-lasting, and very inert. It also has a lower risk of leaking substances than plastic packaging. During the pandemic in 2020, glass materials had a huge chance to grow because of the growing need for injection and vaccine packaging vials and ampoules.
Metals are hard, can't be broken, and weigh less than glass. The pharmaceutical industry will use more metal because there will be more demand for packaging products like aerosol generators, canisters, collapsible tubes, implants, strip packs, and blister packs.
By Product Type:
Based on the type of product, the market is divided into bottles, caps and closures, pre-fillable inhalers, pre-fillable syringes, vials and ampoules, blister packs, bags and pouches, jars and canisters, cartridges, and others. The most important type of product among these is the bottles segment. This market segment is growing because it is cheap, easy to shape, and not too heavy. Solid and liquid medicines, like pills, capsules, syrups, eye drops, and nose drops, are also most often put in plastic bottles. Market growth should be helped by the growing need for plastic bottles in the pharmaceutical industry. Also, the demand for bottles, vials, and jars is expected to grow during the forecast period, which means that more caps and closures will be used.
During the review period, the segment of pre-filled syringes is expected to grow the most. Traditional syringes can be replaced by pre-filled syringes, which are clear, light, ready to be filled, and hard to break. These syringes let you give yourself the right amount of medicine without wasting any. Demand for pre-filled syringes is expected to go up because more people need immediate care and more people are getting diseases like diabetes and heart disease.
Tablets and capsules are kept in blister packs to keep them safe and separate. Also, vials and ampoules, syringes, sutures, and implants are packed in trays with more than one compartment. During the forecast period, blister packs will be used more because there will be more demand for packaging products that can hold multiple doses of medicine. Bags and pouches are used as primary or secondary packaging for single-use items like syringes, various sterile swabs, masks, and gloves that should stay sterile until the package is opened. Bags and pouches are thin, light, strong, hard to tear, and inexpensive packaging.
By Packaging Type:
The market is split into three groups based on the type of packaging: primary, secondary, and tertiary. The most important type of packaging in this market is the primary segment, which is growing at the fastest CAGR. This type of packaging comes into direct contact with the drug. Because of this, it has to meet all the rules and keep the drug's quality. Some of the things in this packaging are plastic bottles, caps and closures, blister packs, pre-filled inhalers, pouches, and medication tubes. These products keep the drugs from getting wet or ruined by chemicals. They also help the drugs last as long as possible.
Secondary segment is used to pack a group of products that were already packed in primary segment. There are boxes and cartons in this part. This packaging gives detailed information about the drug, such as its ingredients, the name and address of the manufacturer, warnings, and how to use and store it. It also helps to tell one drug from another. Tertiary packaging makes it easy to handle bulk items. During the forecast period, the demand for tertiary packaging will go up because more containers, shipping barrels, edge protectors, and pharmaceutical products will be imported and exported.
By Drug Delivery Mode:
Based on how drugs are given, the market is divided into oral drug delivery packaging, topical drug delivery packaging, injectable packaging, ocular drug delivery packaging, pulmonary drug delivery packaging, transdermal drug delivery packaging, nasal drug delivery packaging, and others. The biggest market segment is packaging for drugs that are taken by mouth. Most pharmaceutical preparations, like tablets, capsules, powders, liquids, and semi-liquids, are taken by mouth. Oral drug delivery is a great choice because it is easy to adjust the dose and doesn't cost much to make. This has helped to speed up the development of packaging for oral drug delivery.
The second largest part of the market is packaging for injectables. It includes a wide range of medicines, from solutions for injections to implants. Injectable packaging uses things like prefilled syringes or auto-injector pens, vials, and ampoules. The need for injectable packaging will grow as more drugs are given through injections. Also, the growing number of inflammatory diseases would make more people use topical drugs and increase the need for packaging for topical drug delivery.
Pulmonary drug delivery products are used to treat respiratory diseases. These include Pressurized Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), vaporizers, and nebulizers. The growth of the pulmonary drug delivery packaging segment will be driven by a rise in the use of jars and canisters, plastic actuators, pouches, and boxes for packaging pulmonary drugs.
The largest market share is in North America, and the U.S. is the largest contributor in this area. The rapid growth of the pharmaceutical industry is a big reason why this area is getting bigger. The market in this region is driven by the rising demand for primary packaging products, the rising cost of healthcare, and the rising number of diseases.
The European market is the second largest in the world. Germany, the United Kingdom, and Italy are the top three countries in this market. The growth of this area has been helped by plastic bottles, containers, vials, ampoules, and pre-filled syringes. Also, COVID-19 and other updated rules that governments are using to stop the spread of infectious diseases have helped the pharmaceutical packaging market grow.
China, Japan, and India are the main countries in the Asia-Pacific region that help the market grow. Companies that make pharmaceuticals in these countries are investing more and growing, which is expected to help the market in this region grow. Also, drug companies wanted to make it easier for hospitals and patients to get medical care. As worries about the virus spreading through the surfaces of the packaging grew, pharmaceutical companies saw an opportunity to make more sterile packaging formats.
Latin America and the Middle East and Africa will gain a steady share of the market in the near future because of things like more government support for the pharmaceutical industry, more money being spent on health care, and more people getting sick. Also, the growing number of older people and chronic diseases are driving up the demand for pharmaceuticals, which is driving up the consumption of pharmaceutical packaging.
|Units||Value (USD Billion)
|Growth Rate||CAGR of 5.8% from 2023 to 2030|
|By Product Type||
|By Drug Delivery Mode||
|By Packaging Type||
|Reasons to Purchase this Report||
- May 2022 - Bormioli Pharma, a manufacturer of pharmaceutical glass and plastic primary packaging, announces the launch of EcoPositive, a label for all of the company's sustainable packaging products. This includes recycled glass and plastics, bio-based, biodegradable or compostable plastic solutions, and advanced polymer products.
- April 2022 - Amcor, a global leader in the design and manufacture of responsible packaging solutions, announced the addition of a new, more sustainable High Shield laminate to its pharmaceutical packaging portfolio. New low-carbon, recyclable packaging options help meet the industry's high barrier and performance requirements, while supporting pharmaceutical companies' recycling agendas in two ways.
- June 2022 - Constantia Flexibles introduces a recyclable laminate with improved chemical resistance. The world's third largest flexible packaging manufacturer has launched the first ready-to-recycle single material based on polypropylene (PP) with high chemical resistance for pharmaceutical products.
- July 2021 - Keystone Folding Box Company (USA) reported increased demand for corrugated board based blister packs for pharmaceutical packaging. This increase in demand has been driven by the introduction of new environmental sustainability laws in India and growing demand for child-safe pharmaceutical packaging in the United States.
- April 2021 - Amcor Plc (Switzerland) has begun customer trials of AmSky, a new single-material, recyclable polyethylene blister pack. This brand is recyclable as it does not use polyvinyl chloride.
- Paper & Paperboard
By Product Type:
- Caps & Closures
- Pre-Fillable Inhalers
- Pre-Fillable Syringes
- Vials & Ampoules
- Blister Packs
- Bags & Pouches
- Jars & Canisters
By Drug Delivery Mode:
- Oral Drug Delivery Packaging
- Injectable Packaging
- Topical Drug Delivery Packaging
- Pulmonary Drug Delivery Packaging
- Transdermal Drug Delivery Packaging
- Ocular Drug Delivery Packaging
- Nasal Drug Delivery Packaging
By Packaging Type:
- Amcor Plc (Switzerland)
- Gerresheimer AG (Germany)
- SCHOTT AG (Germany)
- WestRock (U.S.)
- AptarGroup, Inc. (U.S.)
- Berry Global, Inc (U.S.)
- NIPRO (Japan)
- CCL Industries Inc. (Canada)
- West Pharmaceutical Services (U.S.)
- SGD Pharma (France)
- Ardagh Group S.A. (Luxembourg)
- International Paper (U.S.)
- Comar LLC (U.S.)
- Vetter Pharma (Germany)
- Nolato AB (Sweden)
- Origin Pharma Packaging (U.K.)
- Huhtamäki Oyj (Finland)
- Parekhplast India Limited (India)
- Regent Plast Pvt. Ltd. (India)
- Graham Blow Pack Pvt. Limited (India)